Publication | Closed Access

‘Tethering’ fragment-based drug discovery to identify inhibitors of the essential respiratory membrane protein type II NADH dehydrogenase

Drug TargetBiochemistryMedicinePharmacologyRational Drug DesignMolecular DockingDrug Discovery